Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Boer Hr"'
1
Early Discontinuation of Anticonvulsants After Neonatal Seizures
Autor: Gal P, Boer Hr
Publikováno v: Southern Medical Journal. 75:298-300
Seizures in the neonatal period generally respond well to anticonvulsant therapy, but exposure to anticonvulsant medication during the first few months of life may have a detrimental influence on growth and development. The optimal length of therapy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1743750423027e407597ef2d256ddbd
https://doi.org/10.1097/00007611-198203000-00014
Zobrazit plný text záznamu
4
Akademický článek
RAD52-dependent mitotic DNA synthesis is required for genome stability in Cyclin E1-overexpressing cells.
Autor: Audrey A; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Kok YP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Yu S; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., de Haan L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van de Kooij B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van den Tempel N; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Chen M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., de Boer HR; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands. Electronic address: m.vugt@umcg.nl.
Publikováno v: Cell reports [Cell Rep] 2024 Apr 23; Vol. 43 (4), pp. 114116. Date of Electronic Publication: 2024 Apr 15.
Zobrazit plný text záznamu
5
Akademický článek
FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.
Autor: Stok C; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Tsaridou S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van den Tempel N; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Everts M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Wierenga E; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Bakker FJ; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Kok Y; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Alves IT; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Jae LT; Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen-Straße 25, 81377 Munich, Germany., Raas MWD; Oncode Institute, Hubrecht Institute, Royal Academy of Arts and Sciences, Uppsalalaan 8, 3584CT Utrecht, the Netherlands; Theoretical Biology and Bioinformatics, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands., Huis In 't Veld PJ; Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany., de Boer HR; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Bhattacharya A; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Karanika E; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK., Warner H; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Chen M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van de Kooij B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Dessapt J; CHU de Québec Research Center-Université Laval (L'Hôtel-Dieu de Québec), Cancer Research Center, Université Laval, Québec, QC GIR 3S3, Canada., Ter Morsche L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Perepelkina P; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Fradet-Turcotte A; CHU de Québec Research Center-Université Laval (L'Hôtel-Dieu de Québec), Cancer Research Center, Université Laval, Québec, QC GIR 3S3, Canada., Guryev V; European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Tromer EC; Cell Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, Faculty of Science and Engineering, University of Groningen, Nijenborgh 7, 9747 AG Groningen, the Netherlands., Chan KL; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands. Electronic address: m.vugt@umcg.nl.
Publikováno v: Cell reports [Cell Rep] 2023 Jul 25; Vol. 42 (7), pp. 112668. Date of Electronic Publication: 2023 Jun 21.
Zobrazit plný text záznamu
6
Akademický článek
Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51.
Autor: Heijink AM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.; Department of Genetics, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Stok C; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.; MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh. Crewe Road South, Edinburgh, EH4 2XU, Edinburgh, UK., Porubsky D; European Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands.; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA., Manolika EM; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000, CA, Rotterdam, the Netherlands., de Kanter JK; Princess Máxima Center for Pediatric Oncology, 3584, CS, Utrecht, the Netherlands.; Oncode Institute, 3521 AL, Utrecht, the Netherlands., Kok YP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Everts M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., de Boer HR; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Audrey A; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Bakker FJ; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Wierenga E; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands., Tijsterman M; Department of Human Genetics, Leiden University Medical Center, 2333 ZC, Leiden, the Netherlands., Guryev V; European Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands., Spierings DCJ; European Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands., Knipscheer P; Oncode Institute, 3521 AL, Utrecht, the Netherlands.; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology, 3584, CS, Utrecht, the Netherlands.; Oncode Institute, 3521 AL, Utrecht, the Netherlands., Ray Chaudhuri A; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000, CA, Rotterdam, the Netherlands., Lansdorp PM; European Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands. plansdor@bccrc.ca.; Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. plansdor@bccrc.ca.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada. plansdor@bccrc.ca., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands. m.vugt@umcg.nl.
Publikováno v: Nature communications [Nat Commun] 2022 Nov 07; Vol. 13 (1), pp. 6722. Date of Electronic Publication: 2022 Nov 07.
Zobrazit plný text záznamu
7
Akademický článek
Processing DNA lesions during mitosis to prevent genomic instability.
Autor: Audrey A; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands., de Haan L; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands., de Boer HR; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands.
Publikováno v: Biochemical Society transactions [Biochem Soc Trans] 2022 Aug 31; Vol. 50 (4), pp. 1105-1118.
Zobrazit plný text záznamu
8
Akademický článek
RIF1 promotes replication fork protection and efficient restart to maintain genome stability.
Autor: Mukherjee C; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., Tripathi V; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., Manolika EM; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., Heijink AM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands.; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada., Ricci G; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., Merzouk S; Department of Developmental Biology, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., de Boer HR; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Demmers J; Department of Biochemistry, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Ray Chaudhuri A; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, Rotterdam, 3015, CN, The Netherlands. a.raychaudhuri@erasmusmc.nl.
Publikováno v: Nature communications [Nat Commun] 2019 Jul 23; Vol. 10 (1), pp. 3287. Date of Electronic Publication: 2019 Jul 23.
Zobrazit plný text záznamu
9
Akademický článek
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.
Autor: de Boer HR; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Pool M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Joosten E; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Everts M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Samplonius DF; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Helfrich W; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Groen HJM; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., van Cooten S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., Fusetti F; Department of Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, Netherlands Proteomics Centre & Zernike Institute for Advanced Materials, University of Groningen, Groningen, Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands., van Vugt MATM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, Netherlands. m.vugt@umcg.nl.
Publikováno v: Oncogene [Oncogene] 2019 Feb; Vol. 38 (9), pp. 1477-1488. Date of Electronic Publication: 2018 Oct 10.
Zobrazit plný text záznamu
10
Akademický článek
Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.
Autor: Pool M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Boer HR; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Hooge MNL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Vugt MATM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v: Theranostics [Theranostics] 2017 May 27; Vol. 7 (7), pp. 2111-2133. Date of Electronic Publication: 2017 May 27 (Print Publication: 2017).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje